SCHEMBL14764402

SCHEMBL14764402

CC[Ge](CC)(C(=O)c1ccc(O)cc1)C(=O)c1ccc(O)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ESR1 P03372 6/20 0.52
▸ ESR2 Q92731 5/20 0.52
▸ LMNA P02545 2/20 0.52
▸ MAPT P10636 2/20 0.52
▸ ALDH1A1 P00352 2/20 0.52
▸ CHRM1 P11229 2/20 0.52
▸ TSHR P16473 2/20 0.52
▸ SLC6A2 P23975 2/20 0.52
▸ DRD1 P21728 2/20 0.52
▸ MEN1 O00255 1/20 0.52
▸ NR1I2 O75469 1/20 0.52
▸ USP2 O75604 1/20 0.52
▸ NR3C1 P04150 1/20 0.52
▸ TP53 P04637 1/20 0.52
▸ CYP1A2 P05177 1/20 0.52
▸ FYN P06241 1/20 0.52
▸ PGR P06401 1/20 0.52
▸ CHRM2 P08172 1/20 0.52
▸ ADRB1 P08588 1/20 0.52
▸ CYP3A4 P08684 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21879796 0.83 ALDH1A1 (0.50) LMNAMAPTALDH1A1MEN1KMT2A
SCHEMBL274249 0.80 CES1 (0.48) LMNAMAPTALDH1A1TSHRMEN1
SCHEMBL272999 0.78 CA1 (0.57) LMNAMAPTMEN1NR1I2MAPK1
Bromomethane SCHEMBL30082988 0.77 CES1 (0.45) LMNAMAPTALDH1A1TSHRMEN1
SCHEMBL30420427 0.76 CA1 (0.55) LMNAMAPTMEN1NR1I2MAPK1
Butane SCHEMBL28233321 0.71 PARP10 (0.61) ESR1ESR2LMNAMAPTALDH1A1
Butane SCHEMBL27816339 0.71 HSD17B3 (0.57) ESR1ESR2LMNAMAPTALDH1A1
Paroxypropione SCHEMBL440470 0.70 HSD17B3 (0.68) ESR1ESR2LMNAMAPTALDH1A1
Paraben SCHEMBL1685437 0.70 CA2 (0.80) ESR1ESR2LMNAMAPTALDH1A1
Diethylstilbestrol SCHEMBL2440008 0.70 ESR1 (0.78) ESR1ESR2LMNAMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9668946-B2 Dental materials based on monomers having debonding-on-demand properties IVOCLAR VIVADENT AG (LI) 2017-06-06 — — US disclosed
US-20140329929-A1 DENTAL MATERIALS BASED ON MONOMERS HAVING DEBONDING-ON-DEMAND PROPERTIES IVOCLAR VIVADENT AG (LI) 2014-11-06 — — US disclosed
WO-2013034777-A2 DENTAL MATERIALS BASED ON MONOMERS HAVING DEBONDING-ON-DEMAND PROPERTIES IVOCLAR VIVADENT AG (LI) 2013-03-14 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140329929-A1 DENTAL MATERIALS BASED ON MONOMERS HAVING DEBONDING-ON-DEMAND PROPERTIES RCOR3, NR2E1, RER1 ESR1 490/4885ESR2 189/4885LMNA 3049/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback